<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30241185</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">2378-9506</ISSN>                <JournalIssue CitedMedium="Internet">                    <Issue>4</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                    </PubDate>                </JournalIssue>                <Title>Journal of global oncology</Title>                <ISOAbbreviation>J Glob Oncol</ISOAbbreviation>            </Journal>            <ArticleTitle>Breast Cancer and HIV in Sub-Saharan Africa: A Complex Relationship.</ArticleTitle>            <Pagination>                <MedlinePgn>1-11</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1200/JGO.2016.006585</ELocationID>            <Abstract>                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The number and lifespan of individuals living with HIV have increased significantly with the scale-up of antiretroviral therapy. Furthermore, the incidence of breast cancer in women with HIV is growing, especially in sub-Saharan Africa (SSA). However, the association between HIV infection and breast cancer is not well understood.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">A literature search was performed to identify articles published in journals pertaining to breast cancer and HIV, with an emphasis on SSA. Selected US-based studies were also identified for comparison.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 56 studies reviewed, the largest study examined 314 patients with breast cancer and HIV in the United States. There is no consensus on whether HIV infection acts as a pro-oncogenic or antioncogenic factor in breast cancer, and it may have no relation to breast cancer. A higher incidence of breast cancer is reported in high-income countries than in SSA, although breast cancer in SSA presents at a younger age and at a more advanced stage. Some studies show that patients with breast cancer and HIV experience worse chemotherapy toxicity than do patients without HIV. Data on treatment outcomes are limited. The largest study showed worse treatment outcomes in patients with HIV, compared with their counterparts without HIV.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">HIV infection has not been associated with different clinical presentation of breast cancer. However, some evidence suggests that concurrent diagnosis of HIV with breast cancer is associated with increased therapy-related toxicity and worse outcomes. Systematic prospective studies are needed to establish whether there is a specific association between breast cancer and HIV.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Grover</LastName>                    <ForeName>Surbhi</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Surbhi Grover, Yehoda M. Martei, Priya Puri, and Nicola M. Zetola, University of Pennsylvania, Philadelphia, PA; Surbhi Grover, Mohan Narasimhamurthy, and Nicola M. Zetola, University of Botswana, Gaborone, Botswana; Pooja Prabhakar, University of Texas Southwestern Medical Center, Dallas, TX; Miriam Mutebi, Aga Khan University Hospital, Nairobi, Kenya; Onyinye D. Balogun, Weill Cornell Medicine, New York, NY; Aryeh J. Price, California Institute of Technology, Pasadena; Alexandra H. Freeman, Kaiser Permanente San Francisco, San Francisco, CA; Danielle Rodin, University of Toronto, Toronto, Canada; and Sarah Rayne, Helen Joseph Hospital and University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Martei</LastName>                    <ForeName>Yehoda M</ForeName>                    <Initials>YM</Initials>                    <AffiliationInfo>                        <Affiliation>Surbhi Grover, Yehoda M. Martei, Priya Puri, and Nicola M. Zetola, University of Pennsylvania, Philadelphia, PA; Surbhi Grover, Mohan Narasimhamurthy, and Nicola M. Zetola, University of Botswana, Gaborone, Botswana; Pooja Prabhakar, University of Texas Southwestern Medical Center, Dallas, TX; Miriam Mutebi, Aga Khan University Hospital, Nairobi, Kenya; Onyinye D. Balogun, Weill Cornell Medicine, New York, NY; Aryeh J. Price, California Institute of Technology, Pasadena; Alexandra H. Freeman, Kaiser Permanente San Francisco, San Francisco, CA; Danielle Rodin, University of Toronto, Toronto, Canada; and Sarah Rayne, Helen Joseph Hospital and University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Puri</LastName>                    <ForeName>Priya</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Surbhi Grover, Yehoda M. Martei, Priya Puri, and Nicola M. Zetola, University of Pennsylvania, Philadelphia, PA; Surbhi Grover, Mohan Narasimhamurthy, and Nicola M. Zetola, University of Botswana, Gaborone, Botswana; Pooja Prabhakar, University of Texas Southwestern Medical Center, Dallas, TX; Miriam Mutebi, Aga Khan University Hospital, Nairobi, Kenya; Onyinye D. Balogun, Weill Cornell Medicine, New York, NY; Aryeh J. Price, California Institute of Technology, Pasadena; Alexandra H. Freeman, Kaiser Permanente San Francisco, San Francisco, CA; Danielle Rodin, University of Toronto, Toronto, Canada; and Sarah Rayne, Helen Joseph Hospital and University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Prabhakar</LastName>                    <ForeName>Pooja</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Surbhi Grover, Yehoda M. Martei, Priya Puri, and Nicola M. Zetola, University of Pennsylvania, Philadelphia, PA; Surbhi Grover, Mohan Narasimhamurthy, and Nicola M. Zetola, University of Botswana, Gaborone, Botswana; Pooja Prabhakar, University of Texas Southwestern Medical Center, Dallas, TX; Miriam Mutebi, Aga Khan University Hospital, Nairobi, Kenya; Onyinye D. Balogun, Weill Cornell Medicine, New York, NY; Aryeh J. Price, California Institute of Technology, Pasadena; Alexandra H. Freeman, Kaiser Permanente San Francisco, San Francisco, CA; Danielle Rodin, University of Toronto, Toronto, Canada; and Sarah Rayne, Helen Joseph Hospital and University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mutebi</LastName>                    <ForeName>Miriam</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Surbhi Grover, Yehoda M. Martei, Priya Puri, and Nicola M. Zetola, University of Pennsylvania, Philadelphia, PA; Surbhi Grover, Mohan Narasimhamurthy, and Nicola M. Zetola, University of Botswana, Gaborone, Botswana; Pooja Prabhakar, University of Texas Southwestern Medical Center, Dallas, TX; Miriam Mutebi, Aga Khan University Hospital, Nairobi, Kenya; Onyinye D. Balogun, Weill Cornell Medicine, New York, NY; Aryeh J. Price, California Institute of Technology, Pasadena; Alexandra H. Freeman, Kaiser Permanente San Francisco, San Francisco, CA; Danielle Rodin, University of Toronto, Toronto, Canada; and Sarah Rayne, Helen Joseph Hospital and University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Balogun</LastName>                    <ForeName>Onyinye D</ForeName>                    <Initials>OD</Initials>                    <AffiliationInfo>                        <Affiliation>Surbhi Grover, Yehoda M. Martei, Priya Puri, and Nicola M. Zetola, University of Pennsylvania, Philadelphia, PA; Surbhi Grover, Mohan Narasimhamurthy, and Nicola M. Zetola, University of Botswana, Gaborone, Botswana; Pooja Prabhakar, University of Texas Southwestern Medical Center, Dallas, TX; Miriam Mutebi, Aga Khan University Hospital, Nairobi, Kenya; Onyinye D. Balogun, Weill Cornell Medicine, New York, NY; Aryeh J. Price, California Institute of Technology, Pasadena; Alexandra H. Freeman, Kaiser Permanente San Francisco, San Francisco, CA; Danielle Rodin, University of Toronto, Toronto, Canada; and Sarah Rayne, Helen Joseph Hospital and University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Price</LastName>                    <ForeName>Aryeh J</ForeName>                    <Initials>AJ</Initials>                    <AffiliationInfo>                        <Affiliation>Surbhi Grover, Yehoda M. Martei, Priya Puri, and Nicola M. Zetola, University of Pennsylvania, Philadelphia, PA; Surbhi Grover, Mohan Narasimhamurthy, and Nicola M. Zetola, University of Botswana, Gaborone, Botswana; Pooja Prabhakar, University of Texas Southwestern Medical Center, Dallas, TX; Miriam Mutebi, Aga Khan University Hospital, Nairobi, Kenya; Onyinye D. Balogun, Weill Cornell Medicine, New York, NY; Aryeh J. Price, California Institute of Technology, Pasadena; Alexandra H. Freeman, Kaiser Permanente San Francisco, San Francisco, CA; Danielle Rodin, University of Toronto, Toronto, Canada; and Sarah Rayne, Helen Joseph Hospital and University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Freeman</LastName>                    <ForeName>Alexandra H</ForeName>                    <Initials>AH</Initials>                    <AffiliationInfo>                        <Affiliation>Surbhi Grover, Yehoda M. Martei, Priya Puri, and Nicola M. Zetola, University of Pennsylvania, Philadelphia, PA; Surbhi Grover, Mohan Narasimhamurthy, and Nicola M. Zetola, University of Botswana, Gaborone, Botswana; Pooja Prabhakar, University of Texas Southwestern Medical Center, Dallas, TX; Miriam Mutebi, Aga Khan University Hospital, Nairobi, Kenya; Onyinye D. Balogun, Weill Cornell Medicine, New York, NY; Aryeh J. Price, California Institute of Technology, Pasadena; Alexandra H. Freeman, Kaiser Permanente San Francisco, San Francisco, CA; Danielle Rodin, University of Toronto, Toronto, Canada; and Sarah Rayne, Helen Joseph Hospital and University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Narasimhamurthy</LastName>                    <ForeName>Mohan</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Surbhi Grover, Yehoda M. Martei, Priya Puri, and Nicola M. Zetola, University of Pennsylvania, Philadelphia, PA; Surbhi Grover, Mohan Narasimhamurthy, and Nicola M. Zetola, University of Botswana, Gaborone, Botswana; Pooja Prabhakar, University of Texas Southwestern Medical Center, Dallas, TX; Miriam Mutebi, Aga Khan University Hospital, Nairobi, Kenya; Onyinye D. Balogun, Weill Cornell Medicine, New York, NY; Aryeh J. Price, California Institute of Technology, Pasadena; Alexandra H. Freeman, Kaiser Permanente San Francisco, San Francisco, CA; Danielle Rodin, University of Toronto, Toronto, Canada; and Sarah Rayne, Helen Joseph Hospital and University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rodin</LastName>                    <ForeName>Danielle</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Surbhi Grover, Yehoda M. Martei, Priya Puri, and Nicola M. Zetola, University of Pennsylvania, Philadelphia, PA; Surbhi Grover, Mohan Narasimhamurthy, and Nicola M. Zetola, University of Botswana, Gaborone, Botswana; Pooja Prabhakar, University of Texas Southwestern Medical Center, Dallas, TX; Miriam Mutebi, Aga Khan University Hospital, Nairobi, Kenya; Onyinye D. Balogun, Weill Cornell Medicine, New York, NY; Aryeh J. Price, California Institute of Technology, Pasadena; Alexandra H. Freeman, Kaiser Permanente San Francisco, San Francisco, CA; Danielle Rodin, University of Toronto, Toronto, Canada; and Sarah Rayne, Helen Joseph Hospital and University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rayne</LastName>                    <ForeName>Sarah</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Surbhi Grover, Yehoda M. Martei, Priya Puri, and Nicola M. Zetola, University of Pennsylvania, Philadelphia, PA; Surbhi Grover, Mohan Narasimhamurthy, and Nicola M. Zetola, University of Botswana, Gaborone, Botswana; Pooja Prabhakar, University of Texas Southwestern Medical Center, Dallas, TX; Miriam Mutebi, Aga Khan University Hospital, Nairobi, Kenya; Onyinye D. Balogun, Weill Cornell Medicine, New York, NY; Aryeh J. Price, California Institute of Technology, Pasadena; Alexandra H. Freeman, Kaiser Permanente San Francisco, San Francisco, CA; Danielle Rodin, University of Toronto, Toronto, Canada; and Sarah Rayne, Helen Joseph Hospital and University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zetola</LastName>                    <ForeName>Nicola M</ForeName>                    <Initials>NM</Initials>                    <AffiliationInfo>                        <Affiliation>Surbhi Grover, Yehoda M. Martei, Priya Puri, and Nicola M. Zetola, University of Pennsylvania, Philadelphia, PA; Surbhi Grover, Mohan Narasimhamurthy, and Nicola M. Zetola, University of Botswana, Gaborone, Botswana; Pooja Prabhakar, University of Texas Southwestern Medical Center, Dallas, TX; Miriam Mutebi, Aga Khan University Hospital, Nairobi, Kenya; Onyinye D. Balogun, Weill Cornell Medicine, New York, NY; Aryeh J. Price, California Institute of Technology, Pasadena; Alexandra H. Freeman, Kaiser Permanente San Francisco, San Francisco, CA; Danielle Rodin, University of Toronto, Toronto, Canada; and Sarah Rayne, Helen Joseph Hospital and University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2017</Year>                <Month>01</Month>                <Day>11</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>J Glob Oncol</MedlineTA>            <NlmUniqueID>101674751</NlmUniqueID>            <ISSNLinking>2378-9506</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>J Womens Health (Larchmt). 2010 Dec;19(12):2261-6</RefSource>                <PMID Version="1">20950138</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Med Oncol. 2012 Jun;29(2):446-7</RefSource>                <PMID Version="1">21328085</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2015 Mar 1;136(5):E359-86</RefSource>                <PMID Version="1">25220842</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2013 Jul;140(1):177-86</RefSource>                <PMID Version="1">23801159</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Breast Cancer. 2014;2014:189384</RefSource>                <PMID Version="1">25653879</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2002 Nov;76(2):111-6</RefSource>                <PMID Version="1">12452447</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genet Mol Res. 2013 Nov 07;12(4):5289-300</RefSource>                <PMID Version="1">24301790</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>AIDS. 1995 Aug;9(8):859-66</RefSource>                <PMID Version="1">7576319</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2015 Oct 15;5:15162</RefSource>                <PMID Version="1">26469225</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2012 Aug 1;72(15):3839-50</RefSource>                <PMID Version="1">22637726</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Lett. 2005 Jul 28;225(2):261-6</RefSource>                <PMID Version="1">15978329</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2011 Aug;20(4):303-8</RefSource>                <PMID Version="1">21641801</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cytokine Growth Factor Rev. 2002 Apr;13(2):143-54</RefSource>                <PMID Version="1">11900990</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer (Dove Med Press). 2015 Jan 29;7:43-9</RefSource>                <PMID Version="1">25678813</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncol Rep. 2001 May-Jun;8(3):659-61</RefSource>                <PMID Version="1">11295098</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2010 Jan 11;5(1):e8621</RefSource>                <PMID Version="1">20066157</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biochem Biophys Res Commun. 2009 Sep 18;387(2):381-6</RefSource>                <PMID Version="1">19607806</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Patholog Res Int. 2011;2011:925712</RefSource>                <PMID Version="1">21660281</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2014 Aug 1;32(22):2344-50</RefSource>                <PMID Version="1">24982448</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2013 Aug 1;133(3):721-9</RefSource>                <PMID Version="1">23364833</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Int AIDS Soc. 2010 Dec 10;13:51</RefSource>                <PMID Version="1">21143940</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pathology. 1996 Jan;28(1):90-5</RefSource>                <PMID Version="1">8714281</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 1994 Sep;5(7):661-2</RefSource>                <PMID Version="1">7993849</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Int Assoc Physicians AIDS Care (Chic). 2011 Jan-Feb;10(1):30-4</RefSource>                <PMID Version="1">21368012</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Int AIDS Soc. 2011 Mar 28;14:16</RefSource>                <PMID Version="1">21443771</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Breast Cancer. 2014 Apr;14(2):e53-9</RefSource>                <PMID Version="1">24418743</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2014 Apr 23;9(4):e94768</RefSource>                <PMID Version="1">24760049</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Surg. 1999 May;86(5):665-8</RefSource>                <PMID Version="1">10361191</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2003 Dec 1;63(23):8360-5</RefSource>                <PMID Version="1">14678997</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2005 Apr 15;103(8):1540-50</RefSource>                <PMID Version="1">15768434</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>AIDS Patient Care STDS. 2014 Jul;28(7):358-64</RefSource>                <PMID Version="1">24839993</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2014 Apr;144(3):467-78</RefSource>                <PMID Version="1">24604092</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2015 Jul 20;33(21):2376-83</RefSource>                <PMID Version="1">26077242</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Bioinformatics. 2014 Oct 24;15:333</RefSource>                <PMID Version="1">25344230</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 1991 Mar 20;83(6):447-8</RefSource>                <PMID Version="1">1999852</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2012 Aug;135(1):1-15</RefSource>                <PMID Version="1">22274134</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS Med. 2014 Sep 09;11(9):e1001720</RefSource>                <PMID Version="1">25202974</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr HIV/AIDS Rep. 2014 Sep;11(3):271-8</RefSource>                <PMID Version="1">25027062</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J STD AIDS. 2015 Jun;26(7):470-8</RefSource>                <PMID Version="1">25080290</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Int Assoc Provid AIDS Care. 2013 May-Jun;12(3):173-7</RefSource>                <PMID Version="1">23442491</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J STD AIDS. 1999 Dec;10(12):795-802</RefSource>                <PMID Version="1">10639060</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>AIDS. 2014 Mar 27;28(6):881-90</RefSource>                <PMID Version="1">24300545</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Surg Oncol. 2005 Aug 1;91(2):141-2</RefSource>                <PMID Version="1">16028288</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Glob Oncol. 2016 Mar 30;2(5):284-291</RefSource>                <PMID Version="1">28717714</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2003 Sep 15;21(18):3447-53</RefSource>                <PMID Version="1">12972519</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2001 Sep 15;19(18 Suppl):125S-127S</RefSource>                <PMID Version="1">11560987</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast J. 2002 Jul-Aug;8(4):234-43</RefSource>                <PMID Version="1">12100117</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Exp Clin Cancer Res. 2008 Jul 11;27:17</RefSource>                <PMID Version="1">18620559</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2003;5(1):31-6</RefSource>                <PMID Version="1">12559043</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>East Afr Med J. 2002 Mar;79(3):156-62</RefSource>                <PMID Version="1">12389963</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2005 Jun 1;23(16):3686-96</RefSource>                <PMID Version="1">15897552</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Expert Opin Ther Targets. 2014 Nov;18(11):1265-75</RefSource>                <PMID Version="1">25256399</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>AIDS. 2013 Nov 28;27(18):2933-42</RefSource>                <PMID Version="1">23921614</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Intern Med. 2010 Oct 5;153(7):452-60</RefSource>                <PMID Version="1">20921544</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Surg Clin North Am. 2007 Apr;87(2):551-68, xii</RefSource>                <PMID Version="1">17498544</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2015 Aug 12;10(8):e0135602</RefSource>                <PMID Version="1">26267867</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Diagn Pathol. 2009 Jun;13(3):162-7</RefSource>                <PMID Version="1">19433294</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>East Afr Med J. 2002 Dec;79(12):651-7</RefSource>                <PMID Version="1">12678449</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Adv Cancer Res. 2010;107:57-117</RefSource>                <PMID Version="1">20399961</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Breast Cancer. 2001 Oct;2(3):215-20; discussion 221</RefSource>                <PMID Version="1">11899415</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2003;5(5):R144-50</RefSource>                <PMID Version="1">12927045</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Immunol. 2006 Apr;6(4):295-307</RefSource>                <PMID Version="1">16557261</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J HIV Ther. 2007 Sep;12(3):71-2</RefSource>                <PMID Version="1">17962797</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 1997 Mar;33(3):507-8</RefSource>                <PMID Version="1">9155542</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Infect Agent Cancer. 2014 Dec 09;9:42</RefSource>                <PMID Version="1">25926865</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2006 Feb 27;94(4):548-51</RefSource>                <PMID Version="1">16449994</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Diagn Lab Immunol. 1998 Sep;5(5):645-53</RefSource>                <PMID Version="1">9729531</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2014 Jul 15;135(2):432-9</RefSource>                <PMID Version="1">24615279</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biochem Biophys Res Commun. 1999 Sep 7;262(3):615-23</RefSource>                <PMID Version="1">10471373</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2013 Oct 1;133(7):1530-5</RefSource>                <PMID Version="1">23580334</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2005 Apr;90(3):241-7</RefSource>                <PMID Version="1">15830137</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg. 1990 Apr;211(4):492-8</RefSource>                <PMID Version="1">2322041</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Surg Oncol. 2005 Jan 1;89(1):23-7</RefSource>                <PMID Version="1">15612013</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Bull Cancer. 1998 Apr;85(4):299</RefSource>                <PMID Version="1">9752291</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Braz J Infect Dis. 2012 Jul-Aug;16(4):396-7</RefSource>                <PMID Version="1">22846133</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Exp Med. 2003 Nov 3;198(9):1381-9</RefSource>                <PMID Version="1">14597737</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Top Antivir Med. 2014 Jun-Jul;22(3):660-5</RefSource>                <PMID Version="1">25101532</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr HIV Res. 2008 Jan;6(1):34-42</RefSource>                <PMID Version="1">18288973</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>HIV Med. 2007 Jul;8(5):322-3</RefSource>                <PMID Version="1">17561879</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Braz J Infect Dis. 2011 Jul-Aug;15(4):387-93</RefSource>                <PMID Version="1">21861013</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast J. 2011 Jan-Feb;17(1):87-92</RefSource>                <PMID Version="1">21134040</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast J. 2007 Nov-Dec;13(6):622-3</RefSource>                <PMID Version="1">17983411</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Med Assoc. 2000 Jun;92(6):301-5</RefSource>                <PMID Version="1">10918766</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Invest. 2002;20(4):452-7</RefSource>                <PMID Version="1">12094539</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>AIDS Res Hum Retroviruses. 2013 Aug;29(8):1097-104</RefSource>                <PMID Version="1">23581483</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>S Afr Med J. 2014 May;104(5):377-9</RefSource>                <PMID Version="1">25295328</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2011 May 4;103(9):753-62</RefSource>                <PMID Version="1">21483021</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst Monogr. 1998;(23):51-4</RefSource>                <PMID Version="1">9709303</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2012 Dec;48(18):3335-41</RefSource>                <PMID Version="1">22766516</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>23</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>23</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>23</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30241185</ArticleId>            <ArticleId IdType="doi">10.1200/JGO.2016.006585</ArticleId>            <ArticleId IdType="pmc">PMC6180795</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>